tiprankstipranks
Innate Pharma (IPHA)
NASDAQ:IPHA
IPHA
Innate Pharma
RESEARCH TOOLSreports
Want to see IPHA full AI Analyst Report?

Innate Pharma (IPHA) Revenue

135 Followers
StatisticsMarket CapRevenue

Innate Pharma Revenue

Innate Pharma had a revenue of -2.07M in the quarter ending Dec 31, 2025, with -142.65%. This bring the company's revenue in the last twelve months to 2.79M, Increased -45.74%. In the fiscal year ending Dec 31, 2025, Innate Pharma had annual revenue of 2.79M with -77.92% growth.
Revenue (ttm)
2.79M
Revenue Growth
-77.09%
P/S Ratio
60.13
Revenue/Employee
$17,098
Employees
163
Market Cap
$167.59M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
2.79M-9.83M-77.92%
Dec 31, 2024
12.62M-39.28M-75.68%
Dec 31, 2023
51.90M-5.77M-10.01%
Dec 31, 2022
57.67M45.56M+376.17%
Dec 31, 2021
12.11M-57.66M-82.64%
Dec 31, 2020
69.77M800.00K+1.16%
Dec 31, 2019
68.97M-10.92M-13.67%
Dec 31, 2018
79.89M47.26M+144.83%
Dec 31, 2017
32.63M――